Dr. Mohammed Edrees Alomar, MD

Dr. Alomar practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Alomar's NPI, 1245507227, was assigned on November 19, 2011. Dr. Alomar graduated from Other in 2009. Dr. Alomar holds Florida license ME139811.

Dr. Alomar's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Alomar also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Dr. Alomar's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. Dr. Alomar is also affiliated with Tampa General Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Dr. Alomar to 1 more hospital, 3 group practices and clinics, 2 medical groups, 1 breast imaging center and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alomar practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Alomar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Alomar is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Alomar's licenses on file in 2 states: Florida and New Jersey.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease, deep vein thrombosis (DVT) and heart blockage among the conditions Dr. Alomar treats.

CMS data shows 2,877 Medicare services from Dr. Alomar across 14 procedure codes in 2024, for 1,128 Medicare patients. Medicare paid $117,424 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,128 Medicare patients who saw Dr. Alomar in 2024. The largest group is 65 to 74, with 590 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 3.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alomar's median patient age at 70, with 46% women.

In 2024, Dr. Alomar wrote 2,395 Medicare Part D claims for 407 patients. 71% of them were for generic drugs. CMS names the drug for 2,243 of them, across 39 drugs with 11 or more claims each, at $1,128,821 in total drug cost. In 2023, CMS named 2,389 claims across 35 drugs.

Dr. Alomar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alomar as offering telehealth.

Dmand AI links 10 papers to Dr. Alomar, published from 2013 to 2023. 2013 was the busiest year, with 3. The most frequent topics are Coronary Angiography, Cardiac Catheterization and Clinical Alarms. Dr. Alomar has published most often in Catheter Cardiovasc Interv. Dr. Alomar's most frequent co-authors are Subhash Banerjee, MD, Shuaib Abdullah, MD and Eric Fuh, MD.

CMS Open Payments shows 92 general payments to Dr. Alomar from 16 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 91% of the total. Medtronic Vascular, Inc. paid the most, $628.

Dr. Alomar graduated from Other in 2009.

Dr. Alomar is in network with 17 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.